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Idiopathic epilepsy is a common human disorder with a strong genetic component, usually exhibiting complex
inheritance. We describe a new mouse mutation in C57BL/6J mice, called frequent-flyer (Ff), in which disruption of the
gene encoding RNA-binding protein Bruno-like 4 (Brunol4) leads to limbic and severe tonic–clonic seizures in
heterozygous mutants beginning in their third month. Younger heterozygous adults have a reduced seizure threshold.
Although homozygotes do not survive well on the C57BL/6J background, on mixed backgrounds homozygotes and
some heterozygotes also display spike-wave discharges, the electroencephalographic manifestation of absence
epilepsy. Brunol4 is widely expressed in the brain with enrichment in the hippocampus. Gene expression profiling and
subsequent analysis revealed the down-regulation of at least four RNA molecules encoding proteins known to be
involved in neuroexcitability, particularly in mutant hippocampus. Genetic and phenotypic assessment suggests that
Brunol4 deficiency in mice results in a complex seizure phenotype, likely due to the coordinate dysregulation of several
molecules, providing a unique new animal model of epilepsy that mimics the complex genetic architecture of common
disease.
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Introduction
Epilepsy, deﬁned by recurrent seizures resulting from
abnormal, synchronized neuronal ﬁring in the brain, is a
very common neurological disorder. Idiopathic epilepsies do
not have any antecedent disease or injury to the brain and
many are suspected to have a genetic basis. The difﬁculty of
elucidating defective genes underlying common inherited
epilepsies is that they are genetically complex—being caused
by multiple variants that are coinherited in affected
individuals [1,2]. To date, most mutations involved in
idiopathic epilepsy have been found in genes encoding ion
channels or their accessory subunits with a few exceptions,
for example, LGI1 [3] and EFHC1 [4] in humans, [5] and JRK/
JH8 [6,7] in both humans and mice. Such exceptions are of
interest in that they may lead to further understanding of
epilepsy disease mechanisms beyond primary excitability
defects, for example, by identiﬁcation of genes that modulate
the expression or function of the more proximal candidates
for epilepsy—ion channels, neurotransmitter receptors, and
synaptic proteins.
Here we describe the disruption of the expression of an
RNA-binding protein, BRUNOL4 (Bruno-like 4) leading to
partial limbic and tonic–clonic seizures in a new mouse
model of epilepsy called ‘‘frequent-ﬂyer’’ (abbreviated Ff;
gene symbol: Brunol4
Ff). BRUNOL4 (also known as CELF4,
CUG-BP, and ETR-3 like factor 4) belongs to a family of RNA-
binding proteins involved in multiple aspects of RNA
processing such as pre-mRNA splicing [8], mRNA editing
[9], and RNA stability and translation [10]. There are six
family members in both humans and mice with orthologs in
nematode and fruit ﬂy [11]. The murine and human
BRUNOL4 are 99.6% identical at the amino acid level [12].
Mouse knockouts have very recently been published for
Brunol1 and Brunol2, which display spermatagonial and
varied developmental defects, respectively [13,14]. UNC-75, a
neuron-speciﬁc ortholog in C. elegans, shares 47% identity
with the human BRUNOL4 protein. UNC-75 deﬁciency in the
nematode leads to behavioral phenotypes indicative of
abnormal neurotransmission. Human BRUNOL4 can rescue
the unc-75 mutant phenotype, suggesting that UNC-75 and
BRUNOL4 may be involved in ﬁne-tuning synaptic trans-
mission through regulating RNA processing in the nervous
system [15].
In this study we describe the seizure phenotypes of mice
carrying Brunol4 disruption, and begin to explore the
molecular consequences using gene expression proﬁling
and genetic interaction tests. Our studies suggest that Brunol4
deﬁciency alters the expression of several molecules involved
in synaptic function, which, when combined, account for the
complex seizure disorder of frequent-ﬂyer mice.
Results
Origin of the Mutation and Convulsive Seizure Phenotype
The Ff mutation arose from an independent project in
which a series of transgenic mouse lines was generated on the
C57BL/6J (B6) strain background. One line (9/9 transgene
carriers) developed frequent seizures from about three
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transfer. Since the transgene construct was not expressed in
all the lines and since other lines using the same construct did
not have seizures, together suggested that the seizures were
not caused by transgene expression per se. To distinguish
between an unlinked spontaneous mutation and insertional
mutagenesis, affected mice were outcrossed to normal B6
mice. In the next generation, seizures cosegregated with the
presence of the transgene (25/28 carriers displayed seizures
versus 0/22 non-carriers), suggesting a high-penetrance,
dominant mode of inheritance for the seizure phenotype.
Convulsive seizures ranged in severity, the mildest being
muscle twitching in the face and neck, forelimb clonus, and
salivation (Figure 1A). More severe seizures included rearing
and falling, myoclonic jerks, and arching of the back and tail.
In many cases, convulsions were followed by a very wild
running–bouncing phase with occasional tonic–clonic hin-
dlimb extension, but which, unlike the equivalent phase of
some induced seizures, did not result in lethality. Hence, the
allele symbol ‘‘frequent-ﬂyer’’ (Ff) was assigned. The incidence
of these handling-associated seizures was higher in male than
in female mice.
Although handling-associated seizures did not begin until
the third month of age, by 7 wk heterozygotes had markedly
reduced electroconvulsive thresholds (ECT) (Figure 1B). In
addition to convulsive seizure phenotypes, heterozygotes
were also slightly hyperactive, and while slightly smaller at
weaning age, they had a late-onset body weight gain in Ff/þ
heterozygotes (on average 10% heavier than littermate
controls, Figure 1C). Despite the high frequency and the
severity of seizures, Ff/þ heterozygotes do not have a reduced
life span (analyzed up to 24 mo of age). The morphology of
the Ff/þ brain appears normal, as evident in the proper
cortical and hippocampal layering and the lack of overt
gliosis (unpublished data).
Strain Background Effects on Frequent-Flyer Phenotypes
Ff/Ff homozygotes, however, had a much more severe
phenotype; they were born alive at close to Mendelian ratios
but most died during the ﬁrst day. From matings between
heterozygotes, only 1.1% (expect 25%) survived until 4 wk of
age (Table 1). While alive, homozygotes did not display
obvious signs of convulsion or respiratory stress, nor was
there any obvious pathology seen in mutant brains (unpub-
lished data). Future work will be needed to clarify the cause of
perinatal lethality in Ff/Ff homozygotes. However, when we
examined the F2 generation of matings between B6-Ff/þ and
six different inbred mouse strains, a range of survival rates of
homozygotes were observed was with the highest being 8.2%
in crosses with 129S1 (Table 1), suggesting that homozygosity
for B6 allele(s) makes the homozygous phenotype worse, as is
the case with many neurological mutations in mice (e.g., see
[16]). Interestingly, although these F2 hybrid homozygotes
often lived for more than 6 mo, they were smaller than
littermates and also exhibited spontaneous limbic and tonic–
clonic seizures, similar in appearance to those of Ff/þ
heterozygotes, except they were observed as early as 8 wk
(and we suspect that lethal seizures occurred as early as 4 wk).
In addition, Ff/þ heterozygotes on F1 hybrid backgrounds
experienced a lower incidence of convulsive seizures later in
life (unpublished data). These results show that inbred strains
have polymorphisms that attenuate the frequent-ﬂyer phe-
notypes.
Absence Epilepsy in Frequent-Flyer Mutants
The availability of Ff/Ff homozygotes on a mixed genetic
background afforded us the opportunity to determine
whether they show spike-wave discharges (SWD), the electro-
encephalographic manifestation of absence seizures—events
not observed in Ff/þ heterozygotes on the B6 background
(unpublished data). Ff/Ff homozygotes tested on the F2 hybrid
backgrounds (B6 3 129S1 or FVB/NJ) experienced very
frequent SWD (e.g., see Figure 1D and 1E). Interestingly,
heterozygotes in the FVB/NJ cross, but not in the 129S1 cross,
also showed a signiﬁcant rate of SWD (unpublished data).
Together, these results suggest that not only do Ff/Ff
homozygotes have SWD, but that the penetrance or severity
is also modulated by genetic background. Although SWD in
Ff/Ff homozygotes were synchronous, rhythmic, and general-
ized, when compared to those of other SWD-prone mice, such
as stargazer or C3H/HeJ (e.g., see [17,18]), the episodes were
relatively short, averaging 1.5 s in length, and the rhythmicity
was more erratic than in other mutants (Figure 1D). Never-
theless, the animals remained motionless during SWD
episodes, and SWD were suppressed by the anti-absence drug
ethosuximide (Figure 1E, left), suggesting that they are
absence seizures.
Transgenic Insertion Mutation in Brunol4
T od e t e r m i n et h ei d e n t i t yo ft h eg e n ed i s r u p t e db y
transgenic insertion, we cloned and sequenced a unique
transgene-genomic junction fragment (see Materials and
Methods) and found a 100% match to intron 1 of the Brunol4
gene on mouse Chr 18. We then evaluated the impact of
transgene insertion on Brunol4 expression. The insertion
expanded the 74-kb intron 1 of Brunol4 by at least 20 kb, well
upstream of the exons encoding RNA binding motifs
(www.ensembl.org/Mus_musculus, Figure 2). Multiple splice
donor and acceptor sites were detected in the transgene,
suggesting the possibility of the insertion interfering with
normal Brunol4 splicing. In total RNA samples from newborn
mice, no Brunol4 transcript was detected in Ff/Ff homozygotes
and approximately 45% reduction was seen in heterozygotes
(Figure 3A); by real-time reverse-transcriptase PCR (RT-PCR),
similar reduction was observed in the adult brain of Ff/þ
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Author Summary
Epilepsy is a very common brain disorder characterized by recurrent
seizures, resulting from abnormal nerve cell activity in the brain.
Some cases of epilepsy are caused by brain trauma, such as stroke,
infection, tumor, or head injury. Others—so called ‘‘idiopathic’’—do
not have a clear cause. Many idiopathic epilepsies run in families,
but the inheritance patterns and complex seizure types suggest that
they are not due to a single defective gene but instead are caused
by multiple gene defects that are inherited simultaneously in a
patient. This complex inheritance makes it difficult to pinpoint the
underlying defects. Here, we describe a new mutant mouse, called
‘‘frequent-flyer,’’ which has several different types of seizures.
Although these seizures are caused by a mutation in a single gene,
because this gene regulates the expression of many other genes,
which, in turn, cause abnormal nerve cell activity, frequent-flyer
mice provide a unique animal model of epilepsy—mimicking the
complex genetic architecture of common disease.heterozygotes (Figure 3B). We also examined the potential
impact of the transgene on the expression of the neighboring
genes. The genomic region where murine Brunol4 resides is
gene poor. Genes with strong annotation are at least 0.5 Mb
either 59 or 39 away from Brunol4. Expression analysis of the
neighboring genes with potential brain function did not
reveal difference between Ff/Ff homozygous mutants and
normal controls (unpublished data), suggesting that Brunol4 is
the only brain-expressed gene affected by the transgene
insertion. This is consistent with preliminary assessment of a
gene-targeted null allele of Brunol4 that we made recently,
which displays handling-associated seizures in older adults,
resembling those of frequent-ﬂyer mice with both limbic and
wild tonic-clonic phases; younger heterozygotes also have an
unusually low threshold to electroconvulsion (C. L. Mahaffey,
W. N. Frankel, unpublished results).
In order to evaluate the expression pattern of Brunol4 in
adults, we examined RNA from a variety of tissues. Only brain
Figure 1. Phenotypes of Ff Mutant Mice
(A) The posture of a 3-mo-old Ff/þheterozygote mouse at the beginning of a seizure episode. Note the contraction of the muscles of the neck, ears, and
forelimbs and the vertical position of the tail.
(B) Reduced ECT of Ff/þmice. The median response level (CC50) for minimal seizures were as followsþ/þ¼9.17 mA (95% CI 8.83–9.44), Ff/þ¼7.69 mA
(95% CI 7.48–7.9). Squares (u) and triangles (n) indicate individual data points used to construct CC curves in þ/þ and Ff/þ mice, respectively.
(C) Late-onset body-weight gain in Ff/þheterozygous mice. We monitored the body weight between the age of 12 wk and 34 wk of more than 50 male
mice with similar number of mutants and controls. Single-caged mice were excluded from this study. Each mouse was weighed every other week. The
body weights of mutants did not diverge significantly from those of controls until 28 wk of age and the divergence remained afterwards (t-test,
assuming two-tailed distribution and two-sample equal variance, the p-values are 0.024, 0.004, 0.0011, and 0.001 from 28 wk to 34 wk). The average
weight of each genotype at a fixed time-point was plotted against time to generate a growth curve using Microsoft Excel (http://www.microsoft.com/).
(D) EEG recording from a Ff/Ff homozygous mouse. Shown are the six differential recordings from four subcranial electrodes, one in each quadrant
corresponding to front-right (FR), front-left (FL), back-right (BR), and back-left (BL). These traces correspond to one of the longer spike-wave discharge
(SWD) episodes observed.
(E) Treatment of SWD in Ff/Ff homozygous F2 hybrid mice from crosses to FVB (white box) or 129S1 (black). Recording sessions began at least 1 h prior
to ethosuximide, saline, or fluoxetine (Prozac) treatment, and the rate of SWD (minimum criteria:   0.5 s duration, amplitude  23 baseline) was
determined and plotted (‘‘pre’’). Animals were then injected with drug, monitored for an additional hour, and SWD incidence was recorded (post). Lines
between datapoints correspond to each animal pre- and post-treatment. Only the ethosuximide and fluoxetine results were significantly different
comparing treatments (ETX, p ¼ 0.009; fluoxetine, p ¼ 0.019; saline, p ¼ 0.804 matched pairs test).
doi:10.1371/journal.pgen.0030124.g001
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Brunol4 and Epilepsy in Micesamples showed robust signal, despite prolonged exposure
time, suggesting that BRUNOL4 is brain speciﬁc in adults
(Figure 3C), consistent with a recent survey of organ protein
expression in mice that detected BRUNOL4 only in the brain
[19]. At a higher resolution, Brunol4 showed a predominantly
neuronal expression pattern in the brain—labeling was seen
in the cerebral cortex, hippocampus, olfactory bulbs, and the
granule cell layer of the cerebellum (Figure 4). However,
strongest expression in the brain was observed in the
hippocampus where high expression was detected in the
pyramidal neurons of the CA2 and CA3 region. Pyramidal
neurons in CA1, the dentate gyrus granule cells, and the
dentate subgranular zone had weaker expression (Figure 4);
the latter is interesting in light of the observation that some
types of seizure activity may induce neurogenesis in this
region (e.g., see [20]).
Neuroexcitability Candidates Down-Regulated in Mutant
Mice
How might BRUNOL4 deﬁciency result in a complex
seizure phenotype? We hypothesize that BRUNOL4 is
involved in the processing events of one or more mRNA-
encoding proteins that are themselves more directly involved
in synaptic function. Thus, in the absence or reduction of
BRUNOL4, these molecules become dysregulated, leading to
imbalance in neuronal excitability. We carried out micro-
array analysis to detect genes differentially expressed
between coisogenic wild-type and mutant mice. For the
primary screen, newborn Ff/Ff homozygous mutants were
chosen to optimize the signal differential. Of the approx-
imately 39,000 transcripts interrogated, changes in only 459
transcripts (corresponding to approximately 350 independ-
ent genes) were considered statistically signiﬁcant in the Ff/Ff
homozygotes compared with controls (Table S1). Of the 94
down-regulated transcripts (from approximately 70 inde-
pendent genes), the most reduced was Brunol4 itself, with a
signiﬁcant decrease in Ff/Ff homozygotes. Four genes from the
down-regulated list were of obvious interest for an excit-
ability disorder. One encodes serotonin receptor 2c (Htr2c);
Htr2c-null mice are known to experience frequent sponta-
neous seizures, at least on a mixed background, as well as a
reduced seizure threshold [21]. The second encodes synapsin
II (Syn2); seizures precipitated by sensory stimuli were found
previously in Syn2-knockout mice [22]. The third encodes N-
ethylmaleimide-sensitive factor (Nsf), which regulates exocy-
tosis in synaptic transmission, as well as AMPA receptor
trafﬁcking [23,24]. The fourth encodes a-synuclein (Snca), a
neuron-speciﬁc presynaptic protein [25]. All four molecules
have been found in the pyramidal neurons in the hippo-
campus where Brunol4 is highly expressed [25–28]. In
particular, the expression of NSF [27] and synapsin II [28]
were enriched in the CA2-CA3 region, similar to that of
Brunol4.
After conﬁrming the differential expression of all four
transcripts in Ff/Ff-homozygous newborn mice (unpublished
data), expression levels were assessed in adult Ff/þ hetero-
zygous brain regions. All four RNAs had, on average, a 20%–
25% reduction in the B6-Ff/þ hippocampus compared with
controls (Figure 5A and 5B). Moreover, these candidates
showed a signiﬁcant reduction at the protein level in adult
hippocampus of B6-Ff/þ mice (30%–39%; unpublished data),
Table 1. Survival of Brunol4
Ff/Ff Homozygous Mutants in F2 Generation
Partner strain: Brunol4 genotype C57BL/6J 3 C57BL/6J C3H/HeJ EL/Frk FVB/NJ A/J BALB/cByJ 129S1
þ/þ 99 66 74 148 41 76 88
Ff/þ 183 113 143 253 88 136 170
Ff/Ff 3 4 8 24 8 17 23
(%) (1.1) (2.2) (3.6) (5.6) (5.8) (7.4) (8.2)
C57BL/6J (B6)-Ff/þmice were intercrossed to the strains shown above, and progeny were genotyped at wean age. The number of animals with a specific genotype is shown. The percent
that were homozygous Ff/Ff is shown in the bottom row in parentheses, ranging from 1.1% in B6 to 8.2% in 129S1 (expect 25% from Mendelian law).
doi:10.1371/journal.pgen.0030124.t001
Figure 2. Trangene Insertion into the Brunol4 Locus in Ff Mice
(A) Physical map of the transgene insertion point in the first intron of
Brunol4 gene on mouse Chromosome 18. The exact number of copies of
the transgene inserted is currently unknown. It appears to be more than
four copies based on a Southern blot probed with a transgene-specific
probe. The transgene insertion event was a simple addition at the 59 end,
but appeared complex at the 39 end. The last intact copy of the
transgene was inverted to the opposite orientation and there was an 18-
kb deletion in the genomic sequence at the 39 insertion site. Further, a
397-nt fragment from the transgene was left between the last intact
copy of the transgene and the intronic sequence from Brunol4. This 397-
nt fragment was in the same orientation as that of the transgene at the
59 insertion site. The telomeric breakpoint of the transgene insertion was
28,987 nt from the exon 1 splice donor and the centromeric breakpoint
was 27,056 nt from the exon 2 splice acceptor.
(B) The exon/intron structure of the mouse Brunol4 gene. Note the
orientation of the gene is reversed from (A) to facilitate viewing. The
open reading frame starts in exon 1 and ends in exon 12. Three RNA
recognition motifs are predicted in the BRUNOL4 peptide sequence and
the respective coding exons are marked.
doi:10.1371/journal.pgen.0030124.g002
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Brunol4 and Epilepsy in Miceand on a mixed background in Ff/þand Ff/Ff, (25%–32% Ff/þ;
32%–56% Ff/Ff, Figure 5C and 5D). These region-speciﬁc
decreases before the onset of seizures were consistent with
the limbic-seizure phenotype and the overlapping hippo-
campal expression of the four genes with that of Brunol4.
Htr2c Deficiency Contributes to, but Is Not Sufficient for,
Seizure Phenotypes in Brunol4
Ff Mutants
Null mutants of the Htr2c receptor gene have several
phenotypic similarities with Brunol4
Ff/þ heterozygotes, includ-
ing reduced seizure threshold, hyperactivity, and late-onset
weight gain [21,29]. However, the fact that Brunol4
Ff/þ mice on
the B6 strain background experience frequent handling-
provoked convulsive seizures after 3 mo of age, whereas Htr2c
null mutants do not (Y. Yang, W. Frankel, unpublished data),
suggests that down-regulating Htr2c receptor expression is
not sufﬁcient to account for the handling-induced seizures.
To determine whether Htr2c deﬁciency is sufﬁcient to
account for the ECT of Brunol4
Ff/þ mice, we compared seizure
threshold in wild-type, single-mutant, and double-mutant
mice (Figure 6). These studies were all done on the B6 strain,
to avoid the confounding effect of genetic background.
Although the average seizure threshold of Htr2c null mutants
was lower than that of Brunol4
Ff/þ mice by approximately 2
mA, the threshold of double mutants was 1 mA lower still (p¼
0.0003; jtj-test). This suggests that factors in addition to
reduced expression of Htr2c contribute to seizure threshold
in Brunol4
Ff/þ mice. Another difference between Htr2c and
Brunol4 mutant mice is that Htr2c-null mutants do not have
SWD ([21]; our unpublished observations). However, we
found that blocking serotonin reuptake in Brunol4
Ff/Ff
homozygotes by ﬂuoxetine (Prozac) treatment lowers the
SWD incidence by about 50% (Figure 1E, right)—again
suggesting that Htr2c down-regulation combines with other
Brunol4-downstream deﬁciencies to cause the seizure disor-
der of frequent-ﬂyer mutants. Although further tests are
required to determine whether the other causative factors are
Syn2, Nsf, or Snca speciﬁcally, it is clear that the seizure
phenotypes of Brunol4
Ff are determined in a genetically
complex manner.
Discussion
Here, we report on the causal association between Brunol4,
encoding a brain-speciﬁc RNA-binding protein, and the
seizure disorder of frequent-ﬂyer mouse mutants. The origin
of the disorder is a transgenic insertion in the Brunol4 gene,
resulting in very little Brunol4 transcript in homozygotes and
accordingly reduced amount in heterozygotes—suggesting
haploinsufﬁciency. We do not know why the transcript levels
were very low, but one possibility is due to the inverted repeat
in the transgene cluster, creating a potential hairpin
structure that may prevent read-through transcription
(Figure 2). Brunol4
Ff mutant mice have several different kinds
of seizures, depending upon genotype, age, and strain
background. In heterozygotes on a B6 inbred strain back-
ground, these include recurrent limbic and tonic–clonic
seizures—observed readily following routine animal handling
after 3 mo of age—and a signiﬁcantly lower ECT at an earlier
age. Although homozygotes do not usually survive on a
C57BL/6J strain background, on F2 hybrid backgrounds
homozygotes (and some heterozygotes) that survived also
Figure 3. Expression of Brunol4 in Mutant and Wild-Type Mice
(A) Reduced Brunol4 transcript abundance in Ff/þmice. Newborn brain total RNA blot was probed with Brunol4 p1 probe (upper portion) and a mouse
b-actin probe (lower portion) sequentially. Brunol4 transcript was absent from Ff/Ff homozygous newborns, and reduced in abundance in littermateþ/þ
controls. An arrow indicates the position of the Brunol4 transcript.
(B) Relative fold change of Brunol4 by real-time RT-PCR) shown in total RNA from adult cortex in three independent mice of each genotype. Similar
results were observed from all other brain regions.
(C) The expression of Brunol4 is restricted to the brain in adult mice. An RNA blot containing poly-A selected RNA extracted from various adult mouse
tissues was sequentially hybridized with probes specific to Brunol4 and b-actin as a loading control. The position of the size markers (Ambion, http://
www.ambion.com) is shown to the left side of panels.
doi:10.1371/journal.pgen.0030124.g003
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Brunol4 and Epilepsy in Micedisplayed spike-wave discharges, the hallmark of absence
epilepsy.
The prospect of a defective RNA-binding protein such as
BRUNOL4 causing a complex seizure disorder suggests a way
in which a single gene defect can mimic a complex genetic
disease, by impairing the function of multiple molecules
simultaneously. This could happen either as a direct
consequence of its absence, or secondarily, e.g., a cascade of
effects. Microarray analysis between homozygous mutants
and coisogenic control brain yielded a small number of
down-regulated transcripts that were statistically signiﬁcant,
two of which (Htr2c and Syn2) are already known to cause
seizure-related phenotypes when knocked out in mice [21,22],
and two other (Nsf and Snca) have obvious functions that
relate to synaptic transmission. The down-regulation of each
was conﬁrmed in adults, and was greatest in the hippo-
campus, where Brunol4 expression is high. Interestingly, in
addition to seizure susceptibility, Ff/þ heterozygotes display
two nonseizure phenotypes like those of Htr2c null mutants:
mild hyperactivity and late-onset obesity [21,30,31]. This
might suggest that compromised serotonergic transmission is
the major factor of the frequent-ﬂyer phenotype. However,
because Htr2c expression is reduced only modestly (;25%
RNA, ;35% protein) in Ff/þ heterozygotes, compared with
complete loss in Htr2c-null mice, it seems more likely that a
combination of compromised serotonergic transmission and
other defects is responsible for the disorder. Further evidence
for this idea was obtained in the ECT paradigm (additive
phenotypic effects of double mutants), and by observing that
SWD phenotype of Brunol4 homozygotes was partially
mitigated by up-regulation of serotonergic transmission
through blocking the reuptake of serotonin. With any of
the seizure paradigms, it is plausible that reduced synaptic
efﬁcacy, e.g., due to reduced expression of the other three
candidates singled out—Syn2, Nsf, or Snca—is the other
contributing variable. However, we cannot ignore other
genes misregulated in Brunol4 mutants, some with unknown
function (Table S1), since many also expressed selectively
within the hippocampus in B6 mice (Allen Brain Atlas [32]).
We do not know why Brunol4 deﬁciency results in the
decreased expression of these and other transcript RNAs.
BRUNOL4 has been shown to regulate alternative splicing in
cells and tissues without endogenous BRUNOL4 [33–35], but
we did not detect aberrant splice variants in mutant brains, at
least in the subset of transcripts that we analyzed (our
unpublished results). Since members of the Bruno gene
family are involved in RNA editing, stability, and translation,
the possibility exists that Brunol4 is involved in other aspects
of RNA metabolism, for example, in stabilizing transcripts for
translation, a possibility that is supported, in part, by the fact
that the degree of reduction at the RNA level and at the
protein level was not 100% concordant in the mutant
hippocampus (;20%–25% and ;31%–39%, respectively).
However, since many RNA processing steps are believed to be
coupled with transcription [36], BRUNOL4 may indeed serve
multiple roles in RNA metabolism.
Most genes known to cause idiopathic epilepsy encode ion
channels. Brunol4 joins a growing list of non-ion-channel
epilepsy genes in both humans and mice [3–5,7]. It is
noteworthy that the human BRUNOL4 gene is in a region
on human Chromosome 18 showing strong evidence for
linkage with adolescent-onset idiopathic generalized epilepsy
[37], suggesting that BRUNOL4 may be a candidate gene for
these seizure disorders.
Materials and Methods
Mice. Origin of Brunol4
Ff mice. C57BL/6J (B6) transgenic mice were
generated at The Jackson Laboratory (http://www.jax.org/) using a
construct where the expression of murine Ighmbp2 cDNA and
enhanced green ﬂuorescent protein (EGFP) was driven by a bidirec-
tional tetracycline-responsive promoter. Brieﬂy, the coding region of
the Ighmbp2 cDNA was cloned in the pBI-EGFP vector (Clontech,
http://www.clontech.com/). The PvuI linearized transgene (;8.3 kb)
was microinjected into pronuclei of single cell B6 mouse embryos,
which were subsequently implanted into pseudopregnant mice.
B6.129-Htr2c
tm1Jul mice, derived from mice published in 1995 [21],
Figure 4. Brunol4 Expression in Normal Adult Mouse Brain by RNA In Situ
Hybridization
A
33P labeled antisense riboprobe (A) or a sense control probe (B) was
hybridized to 7-lm parasagittal paraffin sections of brain. Note the
positive staining in the olfactory bulb, cerebral cortex, hippocampus, and
cerebellum. Despite several attempts, persistent minor background
signal was observed at the edges of the brain section, especially in the
cerebellum. In order to increase the specificity and better monitor the
signal development, a DIG-labeled antisense riboprobe (C) or a sense
control probe (D) was hybridized to 15-lm parasagittal cryosections of
brain. Representative images are shown focusing on the entire hippo-
campus. Note the intense labeling (blue color) in the CA2 and CA3
regions, consistent with the strong hipocampal signal seen in panel (A).
CB, cerebellum; CO, cerebral cortex; Hi, hippocampus; OB, olfactory bulb.
doi:10.1371/journal.pgen.0030124.g004
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Resource and are now fully congenic on the B6 background after
backcrossing for ten generations. All animals were fed standard
National Institutes of Health diet containing 6% fat and acidiﬁed
water ad libitum. All animal procedures followed Association for
Assessment and Accreditation of Laboratory Animal Care guidelines
and were approved by institutional Animal Care and Use Committee.
ECT. As previously described [38], mice were restrained, a drop of
anesthetic containing 0.5% tetracaine and 0.9% NaCl was placed
onto each eye, and a preset current was applied via silver trans-
corneal electrodes using a electroconvulsive stimulator (Ugo Basile
model 7801; http://www.ugobasile.com). The stimulator was set to
produce rectangular wave pulses with the following parameters: 299
Hz, 0.2 s duration, 1.6 ms width. Sixty Ff/þand 57 littermateþ/þmale
mice (ages 6–9 wk) were tested for ECT over a range of electric
current settings for minimal clonic forebrain seizure and each ECT
response was recorded. The data were analyzed in the computer
program MiniTab (Minitab, http://www.minitab.com/) and a response
curve was generated using the log-Probit procedure. To determine
ECT in double mutants, male mice (ages 6–9 wk) were tested by
increasing the stimulus once daily until at least a minimal clonic
seizure was observed, and the average threshold determined for each
genotype.
Electroencephalogram analysis. Mice were anesthetized with
tribromoethanol (400mg/kg i.p.) Small burr holes were drilled (1
mm anterior to the bregma and 2 mm posterior to the bregma) on
both sides of the skull 2 mm lateral to the midline. Electroencephalo-
gram (EEG) activity was measured by four Teﬂon-coated silver wires
soldered onto a microconnector. The wires were placed between the
dura and the brain and a dental cap was then applied. The mice were
given a post-operative analgesic of carprofen (5 mg/kg subcutaneous)
and were given a 48-h recovery period before recordings were made.
The mice were recorded for a 2-h period on each of the following two
days using the Grass EEG Model 12 Neurodata Acquisition System
and PolyViewPro software program (Grass-Telefactor, http://www.
grasstechnologies.com/). For mice that were treated with ethosux-
Figure 5. Reduced Expression of Four Candidate Genes in Ff /þ Brains
(A) Representative images from three independent RNA blots. Sequential hybridization using Htr2c, Nsf, Snca, Syn2, Gabrb3, and b-actin probes was
carried out on a blot containing poly-A RNA extracted from dissected brain regions. The synapsin II probe detected both synapsin IIa and IIb transcripts
due to alternative splicing/polyadenylation [40] and there was no overt change in the synapsin 2a/2b ratio between Ff/þandþ/þbrains. In addition to
the loading control actin, we examined the expression of Gabrb3, which encodes the b3 subunit of the GABA(A) receptor. Germline targeting of Gabrb3
caused perinatal lethality in homozygous mice and overt seizures in heterozygotes [41]. No significant expression difference was found between Ff/þ
and þ/þ brains. The position of size markers (Ambion) was shown on the left. CO, cerebral cortex; Hb, hindbrain; Hi, hippocampus. F, Ff/þ; þ, þ/þ.
(B) Histogram summarizing results from northern blots, expressed as percent of wild type after normalization to b-actin.
(C) Reduced expression at the protein level; Western blot for HTR2A, HTR2C, NSF, synapsin II, a-synuclein, and b-tubulin. HTR2A, a molecule with
distribution and property similar to HTR2C, was used as a control in addition to b-tubulin. Representative images from experiments with three
independent adult mice on a mixed background are shown.
(D) Histogram summarizing results from (C) in Ff/þ and Ff/Ff mutants on a mixed background, expressed as % of wild type after normalization to b-
tubulin, summarizing data from three independent animals. Error bars throughout are one standard deviation.
doi:10.1371/journal.pgen.0030124.g005
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Brunol4 and Epilepsy in Miceimide (200 mg/kg; Sigma-Aldrich, http://www.sigmaaldrich.com) or
ﬂuoxetine (20 mg/kg, Sigma-Aldrich), on the day following their
second standard EEG recording, mice were recorded for 90 min and
then injected intraperitoneally. They were then recorded for a
minimum of one additional hour. The control mice were injected
intraperitoneally with saline and recorded in the same manner.
Matched pairs tests were done using the program JMP 6.0.3 (SAS,
http://www.sas.com/).
Identiﬁcation of the transgene insertion site. Genomic DNA from
transgenic mice and control mice was digested with BclI, SpeI, BglII,
SphI, and StuI and electrophoresed and blotted onto a Nytron Plus
membrane (Schleicher & Schuell, http://www.whatman.com/). The blot
was probed with an EGFP probe and a unique transgene-genomic
junction fragment was present in StuI-digested DNA at about 3 kb.
The StuI-digested fragment of ;3 kb was cloned into the pBluescript
II-SK vector (Stratagene, http://www.stratagene.com). A vector-speciﬁc
primer and an EGFP primer were used to amplify the junction
fragment. Automated sequencing conﬁrmed the presence of the EGFP
cDNA as well as other vector sequence. A 652-nt fragment did not
match with the pBluescript II-SK vector sequence and was used as a
query to BLAST search the mouse genome. A single perfect match to
intron 1 of the Brunol4 gene was found on mouse Chromosome 18.
The other breakpoint of the transgene insertion was cloned by a PCR
strategy using a transgene-speciﬁc primer and a Brunol4 intron 1
primer. Based on the sequence information around the insertion
breakpoints in the Ff allele, a 3-primer PCR assay was designed to
detect the Ff allele and wild-type allele. Primers for this assay are: s3gtf,
59-CTCTTCATCCCTTCTGGCAAGTAG-39;s 3 g t r ,5 9-GTATTCAA-
CAATTCCGTGTCGCCC-39; and s3gtr2, 59-CCACACAGAGACCAA-
GAAGATTCC-39.A t5 58C annealing temperature, 35 cycles, standard
PCR conditions, the s3gtf/s3gtr2 primers produce a 672-bp wild-type
allele, and the s3gtf/s3gtr primers produce a 464-bp mutant allele.
Northern blot analysis and quantiﬁcation. Total RNA was prepared
from newborn brain, adult brain and dissected brain regions using
TRIzol reagent (Invitrogen, http://www.invitrogen.com). Two probes
were generated for Brunol4, p1 containing 59 UTR and exon1 59 to the
insertion site and p2 containing the region between BRUNOL49s
second and third RNA recognition motif. Both probes detected a
single transcript on northern blots and p2 was also used for in situ
analysis. Hybridization was carried out in formamide-based solution
at 42 8C overnight and the blot was washed and exposed to an X-ray
ﬁlm at 80 8C. The same blot was stripped and reprobed with a mouse
b-actin probe. Films were imaged by Fuji Luminescent Image
Analyzer LAS-1000 Plus (http://fujiﬁlmlifescienceusa.com) and sub-
sequently quantiﬁed by Fuji Image Gauge Ver. 3.4.
Real-time reverse-transcription PCR. Total RNA was prepared
from the cerebral cortex of adult B6-Ff/þand and B6-þ/þ/littermates
with Trizol (Invitrogen, http://www.invitrogen.com) and treated with
DNase I (Promega, http://www.promega.com) under the manufac-
turer’s suggested conditions. RNA (2 lg) was reverse transcribed with
AMV reverse transcriptase (Promega). The cDNA was diluted 20-fold,
and 1.5 ll was added to qPCR Mastermix Plus for SYBR Green I
(Eurogentec, http://www.eurogentec.be) with pairs of the following
primers: beta-actinF( 5 9-CATTGCTGACAGGATGCAGAA-39) and beta-
actinR( 5 9-GCCACCGATCCACACAGAGT-39), Be1u (59-TCGCAG-
TAGGTGAGGAAAGCGCAG-39) and Be2d (59-TCGCAGTAGGTGAG-
GAAAGCGCAG-39), corresponding to Brunol4 exon 1 forward and
exon 2 reverse, respectively. The PCR reactions were analyzed on an
ABI Prism 7000 Sequence Detection System (PerkinElmer, http://
www.perkinelmer.com/). The PCR ampliﬁcations from three pairs of
age-matched mice were run in triplicate. Ampliﬁcation of the correct
size products was conﬁrmed by agarose gel electrophoresis.
RNA in situ hybridization. Thin brain sections (7 lm) from 10-wk-
old B6 male mice were hybridized with
33P probes overnight at 50 8C
and washed, RNase A treated, dehydrated, and air dried. Slides were
dipped in liquid emulsion (Kodak, http://www.kodak.com/) and images
were developed 5 d afterwards. For DIG-based in situ analysis, 15-lm
cryosections were hybridized with DIG probes overnight at 65 8C and
washed extensively before an overnight incubation of alkaline
phosphatase–conjugated anti-DIG antibody (1:2,000, Roche, http://
www.roche.com/). Staining signal was developed using BM purple
(Roche) at room temperature for 12 h.
Microarray analysis. Total RNA was prepared from six male
newborn heads (3 Ff/Ff and 3 þ/þ). 10 lg of total RNA was used to
generate 15 lg of cRNA for hybridization to the Affymetrix 430 v2.0
Gene Chip (Affymetrix, http://www.affymetrix.com/) according to
manufacturer’s recommendation. Using the R/maanova package
[39], an analysis of variance (ANOVA) model was applied to the data,
and F1, F2, F3, and Fs test statistics were constructed along with their
permutation p-values. Changes in 459 transcripts were considered
statistically signiﬁcant among the 39,000 transcripts interrogated.
Antibodies for Western blotting. The primary antibodies and the
dilutions were: a-HTR2A, 1:500 (BD Pharmingen, http://
www.bdbiosciences.com/); a-HTR2C, 1:500 (Immunostar, http://
www.immunostar.com/); a-NSF, 1:1,000 (H-300, Santa Cruz Bio-
technology, http://www.scbt.com/); a-Synapsin 2, 1:5,000 (Stressgen,
http://www.nventacorp.com/); a-alpha-synuclein, 1:250 (BD Trans-
duction, http://www.bdbiosciences.com/); and a-beta-tubulin,
1:1,000 (Sigma). The secondary antibodies and the dilutions were:
HRP a-mouse, 1:6,000 (Zymed, http://www.invitrogen.com/) and
HRP a-rabbit, 1:2,000 (PerkinElmer).
Northern blot probes. The following probes were designed to
detect expression differences among the putative BRUNOL4 target
RNAs between Ff/þ and þ/þ brains: (1) Htr2c, 437-nt probe in exon 6,
the last nucleotide is 43 nt 39 of the TAA stop codon. (2) Nsf, 470-nt
probe as described in [27]. (3) Syn2, 234-nt probe in exon 1, the ﬁrst
nucleotide is 90 nt 39 of the ATG start codon. This probe was able to
detect the two alternatively polyadenylated Syn2 transcripts. (4) Snca,
416-nt probe in exon 6, the ﬁrst nucleotide is 37 nt 39 of the TAA stop
codon. (5) Gabrb3, 412-nt probe speciﬁc to the 39 end of the coding
sequence, the last nucleotide is 14 nt 59 of the TGA stop codon.
Western blot. Hippocampi were dissected from three male Ff/þ
mice (before the onset of handling-provoked seizures) and three þ/þ
littermates. Protein extracts were made using RIPA buffer with
proteinase inhibitors (Roche) and subsequently quantiﬁed using the
Bradford reagent (Bio-Rad, http://www.bio-rad.com/). Protein (50 lg)
from each sample was loaded and probed with the primary antibody
and a secondary peroxidase-conjugated antibody and visualized with
the ECL plus kit (Amersham, http://www.amersham.com/). The nitro-
cellulose membrane was incubated with Restore Western blot
stripping buffer (Pierce, http://www.piercenet.com/) at 37 8C for 30
min to remove all the antibodies. The membrane was washed and
subsequently reprobed with a different set of antibodies. Signals were
quantiﬁed using the method described above.
Supporting Information
Table S1. List of Genes with Differential Expression between Ff/Ff
Homozygous and Wild-Type Newborn Mice
Microarray analysis was carried out as described in Materials and
Methods. Down-regulated transcripts (94) are listed ﬁrst, followed by
365 up-regulated transcripts.
Figure 6. Genetic Interaction between Brunol4 and Htr2c for ECT
Shown is a histogram of average threshold (in mA) to a minimal clonic or
maximal tonic hindlimb extension seizure, determined as described in
Materials and Methods, for wild-type (þ/þ, þ/þ), single mutant (Ff/þ, þ/þ
or B6-Htr2c
tm1Jul/Y), or double mutant (Ff/þ; Htr2c
tm1Jul/Y), littermates
from crosses between B6-Htr2c
tm1Jul/Y and B6-Ff/þ mice.
doi:10.1371/journal.pgen.0030124.g006
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Accession Numbers
The National Center for Biotechnology Information (NCBI) Nucleo-
tide database (http://www.ncbi.nlm.nih.gov/sites/
entrez?db¼Nucleotide) accession number for intron 1 of the Brunol4
gene on mouse Chr 18 is EF639873.
Acknowledgments
We thank Jason Affourtit, Sandy Daigle, Barbara Beyer, Carolyne
Dunbar, Jonette Gilley, Neena Haider, Sonya Kamdar, Yong Woo, and
Weidong Zhang for technical assistance. We also thank Susan
Ackerman, Albert Becker, Robert Burgess, and Verity Letts for
comments and advice.
Author contributions. YY and WNF conceived and designed the
experiments and wrote the paper. YY, CLM, NB, and WNF performed
the experiments and analyzed the data. TPM and GAC contributed
reagents/materials/analysis tools.
Funding. The Jackson Laboratory’s Gene Expression and DNA
Sequencing services were subsidized by an NCI core grant CA34196.
This work was supported by a grant from the National Institutes of
Health (NS31348 to WNF). YY was supported by a TJL Postdoctoral
Fellowship and a research award from Citizens United for Research
in Epilepsy (CURE).
Competing interests. The authors have declared that no competing
interests exist.
References
1. Marini C, Scheffer IE, Crossland KM, Grinton BE, Phillips FL, et al. (2004)
Genetic architecture of idiopathic generalized epilepsy: Clinical genetic
analysis of 55 multiplex families. Epilepsia 45: 467–478.
2. Ottman R, Hauser WA, Barker-Cummings C, Lee JH, Risch N (1997)
Segregation analysis of cryptogenic epilepsy and an empirical test of the
validity of the results. Am J Hum Genet 60: 667–675.
3. Kalachikov S, Evgrafov O, Ross B, Winawer M, Barker-Cummings C, et al.
(2002) Mutations in LGI1 cause autosomal-dominant partial epilepsy with
auditory features. Nat Genet 30: 335–341.
4. Suzuki T, Delgado-Escueta AV, Aguan K, Alonso ME, Shi J, et al. (2004)
Mutations in EFHC1 cause juvenile myoclonic epilepsy. Nat Genet 36: 842–
849.
5. Skradski SL, Clark AM, Jiang H, White HS, Fu YH, et al. (2001) A novel gene
causing a mendelian audiogenic mouse epilepsy. Neuron 31: 537–544.
6. Moore T, Hecquet S, McLellann A, Ville D, Grid D, et al. (2001)
Polymorphism analysis of JRK/JH8, the human homologue of mouse jerky,
and description of a rare mutation in a case of CAE evolving to JME.
Epilepsy Res 46: 157–167.
7. Toth M, Grimsby J, Buzsaki G, Donovan GP (1995) Epileptic seizures caused
by inactivation of a novel gene, jerky, related to centromere binding
protein-B in transgenic mice. Nat Genet 11: 71–75.
8. Philips AV, Timchenko LT, Cooper TA (1998) Disruption of splicing
regulated by a CUG-binding protein in myotonic dystrophy. Science 280:
737–741.
9. Anant S, Henderson JO, Mukhopadhyay D, Navaratnam N, Kennedy S, et al.
(2001) Novel role for RNA-binding protein CUGBP2 in mammalian RNA
editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by
interacting with apobec-1 and ACF, the apobec-1 complementation factor.
J Biol Chem 276: 47338–47351.
10. Mukhopadhyay D, Houchen CW, Kennedy S, Dieckgraefe BK, Anant S
(2003) Coupled mRNA stabilization and translational silencing of cyclo-
oxygenase-2 by a novel RNA binding protein, CUGBP2. Mol Cell 11: 113–
126.
11. Ladd AN, Nguyen NH, Malhotra K, Cooper TA (2004) CELF6, a member of
the CELF family of RNA-binding proteins, regulates muscle-speciﬁc
splicing enhancer-dependent alternative splicing. J Biol Chem 279:
17756–17764.
12. Meins M, Schlickum S, Wilhelm C, Missbach J, Yadav S, et al. (2002)
Identiﬁcation and characterization of murine Brunol4, a new member of
the elav/bruno family. Cytogenet Genome Res 97: 254–260.
13. Dev A, Nayernia K, Meins M, Adham I, Lacone F, et al. (2007) Mice deﬁcient
for RNA-binding protein brunol1 show reduction of spermatogenesis but
are fertile. Mol Reprod Dev.
14. Kress C, Gautier-Courteille C, Osborne HB, Babinet C, Paillard L (2007)
Inactivation of CUG-BP1/CELF1 causes growth, viability, and spermato-
genesis defects in mice. Mol Cell Biol 27: 1146–1157.
15. Loria PM, Duke A, Rand JB, Hobert O (2003) Two neuronal, nuclear-
localized RNA binding proteins involved in synaptic transmission. Curr
Biol 13: 1317–1323.
16. Buchner DA, Trudeau M, Meisler MH (2003) SCNM1, a putative RNA
splicing factor that modiﬁes disease severity in mice. Science 301: 967–969.
17. Frankel WN, Beyer B, Maxwell CR, Pretel S, Letts VA, et al. (2005)
Development of a new genetic model for absence epilepsy: Spike-wave
seizures in C3H/He and backcross mice. J Neurosci 25: 3452–3458.
18. Noebels JL, Qiao X, Bronson RT, Spencer C, Davisson MT (1990) Stargazer:
A new neurological mutant on Chromosome 15 in the mouse with
prolonged cortical seizures. Epilepsy Res 7: 129–135.
19. Kislinger T, Cox B, Kannan A, Chung C, Hu P, et al. (2006) Global survey of
organ and organelle protein expression in mouse: Combined proteomic
and transcriptomic proﬁling. Cell 125: 173–186.
20. Smith PD, McLean KJ, Murphy MA, Turnley AM, Cook MJ (2005) Seizures,
not hippocampal neuronal death, provoke neurogenesis in a mouse rapid
electrical amygdala kindling model of seizures. Neuroscience 136: 405–415.
21. Tecott LH, Sun LM, Akana SF, Strack AM, Lowenstein DH, et al. (1995)
Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors.
Nature 374: 542–546.
22. Rosahl TW, Spillane D, Missler M, Herz J, Selig DK, et al. (1995) Essential
functions of synapsins I and II in synaptic vesicle regulation. Nature 375:
488–493.
23. Schiavo G, Gmachl MJ, Stenbeck G, Sollner TH, Rothman JE (1995) A
possible docking and fusion particle for synaptic transmission. Nature 378:
733–736.
24. Shi S, Hayashi Y, Esteban JA, Malinow R (2001) Subunit-speciﬁc rules
governing AMPA receptor trafﬁcking to synapses in hippocampal
pyramidal neurons. Cell 105: 331–343.
25. Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, et al. (1995) The
precursor protein of non-A beta component of Alzheimer’s disease
amyloid is a presynaptic protein of the central nervous system. Neuron
14: 467–475.
26. Hoffman BJ, Mezey E (1989) Distribution of serotonin 5-HT1C receptor
mRNA in adult rat brain. FEBS Lett 247: 453–462.
27. Puschel AW, O’Connor V, Betz H (1994) The N-ethylmaleimide-sensitive
fusion protein (NSF) is preferentially expressed in the nervous system.
FEBS Lett 347: 55–58.
28. Ullrich B, Sudhof TC (1995) Differential distributions of novel synapto-
tagmins: Comparison to synapsins. Neuropharmacology 34: 1371–1377.
29. Nonogaki K, Abdallah L, Goulding EH, Bonasera SJ, Tecott LH (2003)
Hyperactivity and reduced energy cost of physical activity in serotonin 5-
HT(2C) receptor mutant mice. Diabetes 52: 315–320.
30. Applegate CD, Tecott LH (1998) Global increases in seizure susceptibility
in mice lacking 5-HT2C receptors: A behavioral analysis. Exp Neurol 154:
522–530.
31. Nonogaki K, Strack AM, Dallman MF, Tecott LH (1998) Leptin-independ-
ent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-
HT2C receptor gene. Nat Med 4: 1152–1156.
32. Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, et al. (2007) Genome-
wide atlas of gene expression in the adult mouse brain. Nature 445: 168–
176.
33. Singh G, Charlet BN, Han J, Cooper TA (2004) ETR-3 and CELF4 protein
domains required for RNA binding and splicing activity in vivo. Nucleic
Acids Res 32: 1232–1241.
34. Faustino NA, Cooper TA (2005) Identiﬁcation of putative new splicing
targets for ETR-3 using sequences identiﬁed by systematic evolution of
ligands by exponential enrichment. Mol Cell Biol 25: 879–887.
35. Ladd AN, Taffet G, Hartley C, Kearney DL, Cooper TA (2005) Cardiac
tissue-speciﬁc repression of CELF activity disrupts alternative splicing and
causes cardiomyopathy. Mol Cell Biol 25: 6267–6278.
36. Maniatis T, Reed R (2002) An extensive network of coupling among gene
expression machines. Nature 416: 499–506.
37. Durner M, Keddache MA, Tomasini L, Shinnar S, Resor SR, et al. (2001)
Genome scan of idiopathic generalized epilepsy: Evidence for major
susceptibility gene and modifying genes inﬂuencing the seizure type. Ann
Neurol 49: 328–335.
38. Frankel WN, Taylor L, Beyer B, Tempel BL, White HS (2001) Electro-
convulsive thresholds of inbred mouse strains. Genomics 74: 306–312.
39. Broman KW, Wu H, Sen S, Churchill GA (2003) R/qtl: QTL mapping in
experimental crosses. Bioinformatics 19: 889–890.
40. Sudhof TC, Czernik AJ, Kao HT, Takei K, Johnston PA, et al. (1989)
Synapsins: Mosaics of shared and individual domains in a family of synaptic
vesicle phosphoproteins. Science 245: 1474–1480.
41. DeLorey TM, Handforth A, Anagnostaras SG, Homanics GE, Minassian BA,
et al. (1998) Mice lacking the beta3 subunit of the GABAA receptor have
the epilepsy phenotype and many of the behavioral characteristics of
Angelman syndrome. J Neurosci 18: 8505–8514.
PLoS Genetics | www.plosgenetics.org July 2007 | Volume 3 | Issue 7 | e124 1283
Brunol4 and Epilepsy in Mice